ForumIAS LATEST
- SFG FRC 2027 | Program starts from 15th Dec. 2026 | Admissions open for Tranche-1 Entrance Test till 25th Oct. 2026 Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 21st October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
Source: Indian Express
What is the news?
A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute (IVI) in partnership with Bharat Biotech International Ltd (BBIL) has begun in Costa Rica.
| Read more: World may soon get a vaccine against Chikungunya |
What is Chikungunya?
It is a viral disease transmitted to humans by infected mosquitoes
How is it transmitted?
Chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes. These are the same mosquitoes that transmit the dengue virus.
Symptoms:
- The most common symptoms of infection are fever and joint pain
- Other symptoms may include headache, muscle pain, joint swelling, or rash.
Vaccination: Presently, there is no vaccine to prevent or medicine to treat Chikungunya virus infection.
